SOPHIA ANTIPOLIS, France – November 04, 2025 │ French biotechnology company Core Biogenesis has recently presented at Cosmetic 360, its oleosome-based growth factor platform promising anti-aging efficacy and supported by a sustainable and scientifically proven approach. Knowmade deciphers the science and the intellectual property behind the innovation. About Core Biogenesis Core Biogenesis is a biotechnology[…]
SOPHIA ANTIPOLIS, France – October 24, 2025 │ Hansoh Pharmaceutical has signed a license agreement with Roche to develop HS-20110, a CDH17-targeting antibody-drug conjugate (ADC) utilizing a clinically validated topoisomerase inhibitor payload. Hansoh Pharma gives Roche an exclusive worldwide license (excluding the Chinese Mainland, Hong Kong, Macau and Taiwan) to advance the clinical development and[…]
SOPHIA ANTIPOLIS, France – October 17, 2025 │ This quarter, KnowMade’s Therapeutic mRNA patent monitoring service reveals two emerging players shaping the next wave of RNA innovation: Parcel Bio, pioneering nanoparticle-free delivery, and ArkeaBio, developing mRNA vaccines for methane mitigation. Two Emerging Players Expand the Frontiers of Therapeutic mRNA Innovation Two new entrants have emerged[…]
SOPHIA ANTIPOLIS, France – October 08, 2025 │ French startup Byome Labs has successfully closed a seed funding round to accelerate the industrialization of Byome Derma, its fast and simple skin microbiome testing solution. KnowMade decodes the science behind the news. About Byome Labs Founded in 2023, Byome Labs is an innovative deeptech startup headquartered[…]